Briakinumab, chemically identified as 339308-60-0, represents a unique biologic therapy exhibiting considerable application in the treatment of moderate to severe plaque condition and severe alopecia thinning. This monoclonal antibody selectively blocks the interleukin and IL-23 pathways, crucial players in the immune process underlying these di… Read More

Rilotumumab, formerly designated AMG 102, is a monoclonal antibody often utilized Rilotumumab buy online as a valuable research means to probe the processes contributing to tumor growth . The experimental specifically targets the IGFR, a major regulator in several malignant forms. Rese… Read More

Recombinant mouse granulocyte colony-stimulating protein, often abbreviated as G-CSF, represents a valuable therapeutic agent in modern clinical practice. Produced via advanced genetic methods, this factor is essentially a purified version of a endogenously occurring growth factor that promotes the generation of neutrophils. Its clinical uses ar… Read More